Biomea Fusion (NASDAQ:BMEA) Upgraded at Rodman & Renshaw
Rodman & Renshaw upgraded shares of Biomea Fusion (NASDAQ:BMEA – Free Report) from a neutral rating to a buy rating in a research note issued to investors on Thursday, Marketbeat.com reports. The firm currently has $18.00 price target on the stock. Other analysts have also issued reports about the stock. Citigroup cut their target price […]
29 Sep 07:13 · The Markets Daily